Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-30 4:21 pm Unchanged | 13D | Cara Therapeutics Inc. CARA | Vifor (International) Ltd | 7,396,770 13.500% | 0 (Unchanged) | View |
| 2024-07-08 4:32 pm Sale | 13G | Cara Therapeutics Inc. CARA | BlackRock Inc. BLK | 744,707 1.400% | -2,809,551 (-79.05%) | View |
| 2024-02-13 6:50 pm Sale | 13G | Cara Therapeutics Inc. CARA | Bain Capital Life Sciences Opportunities III LP | 0 0.000% | -2,696,030 (Position Closed) | View |
| 2024-02-13 5:01 pm Sale | 13G | Cara Therapeutics Inc. CARA | VANGUARD GROUP INC | 2,631,067 4.830% | -470,657 (-15.17%) | View |
| 2024-01-29 3:26 pm Sale | 13G | Cara Therapeutics Inc. CARA | BlackRock Inc. BLK | 3,554,258 6.500% | -147,710 (-3.99%) | View |
| 2023-07-25 4:40 pm Unchanged | 13G | Cara Therapeutics Inc. CARA | Vifor (International) Ltd | 7,396,770 13.700% | 0 (Unchanged) | View |
| 2023-07-07 4:35 pm Sale | 13G | Cara Therapeutics Inc. CARA | BlackRock Inc. BLK | 3,701,968 6.900% | -4,028,561 (-52.11%) | View |
| 2023-02-09 11:12 am Purchase | 13G | Cara Therapeutics Inc. CARA | VANGUARD GROUP INC | 3,101,724 5.770% | 68,962 (+2.27%) | View |
| 2023-01-26 08:52 am Unchanged | 13G | Cara Therapeutics Inc. CARA | BlackRock Inc. BLK | 7,730,529 14.400% | 0 (Unchanged) | View |
| 2023-01-20 09:43 am Purchase | 13G | Cara Therapeutics Inc. CARA | BlackRock Inc. BLK | 7,730,529 14.400% | 531,403 (+7.38%) | View |
| 2022-11-18 4:16 pm Purchase | 13G | Cara Therapeutics Inc. CARA | Bain Capital Life Sciences Opportunities III LP | 2,696,030 5.000% | 2,696,030 (New Position) | View |
| 2022-02-14 6:16 pm Sale | 13G | Cara Therapeutics Inc. CARA | FIRST MANHATTAN CO. LLC. | 0 0.000% | -3,212,796 (Position Closed) | View |
| 2022-02-14 11:35 am Sale | 13G | Cara Therapeutics Inc. CARA | RHO Ventures VI LP | 782 0.000% | -2,798,276 (-99.97%) | View |
| 2022-02-09 3:33 pm Purchase | 13G | Cara Therapeutics Inc. CARA | VANGUARD GROUP INC | 3,032,762 5.670% | 3,032,762 (New Position) | View |
| 2022-01-28 1:54 pm Sale | 13G | Cara Therapeutics Inc. CARA | BlackRock Inc. BLK | 7,199,126 13.500% | -35,151 (-0.49%) | View |
| 2021-10-21 4:15 pm Purchase | 13G | Cara Therapeutics Inc. CARA | Vifor (International) Ltd | 7,396,770 13.900% | 3,282,391 (+79.78%) | View |
| 2021-05-07 5:09 pm Purchase | 13G | Cara Therapeutics Inc. CARA | BlackRock Inc. BLK | 7,234,277 14.500% | 3,602,011 (+99.17%) | View |
| 2021-02-16 2:41 pm Purchase | 13G | Cara Therapeutics Inc. CARA | FIRST MANHATTAN CO. LLC. | 3,212,796 6.450% | 3,212,796 (New Position) | View |
| 2021-02-16 12:23 pm Sale | 13G | Cara Therapeutics Inc. CARA | PRICE T ROWE ASSOCIATES INC | 2,429,235 4.800% | -2,231,379 (-47.88%) | View |
| 2021-02-12 3:42 pm Sale | 13G | Cara Therapeutics Inc. CARA | RHO Ventures VI LP | 2,799,058 5.600% | -393,999 (-12.34%) | View |